Puja Khanna, MD
@pujakhannamd.bsky.social
π€ 18
π₯ 26
π 1
Clinical Director of Women's Health Inflammatory Bowel Disease Institute Cedars-Sinai Medical Center
reposted by
Puja Khanna, MD
Cedars Sinai IBDI
2 days ago
Our very own Dr.
@pujakhannamd.bsky.social
joined
@connectingtocure.bsky.social
's live podcast event 'A Body Owner's Guide to IBD' on May 16th. An incredible evening of education, advocacy, & community. So proud of Dr. Khanna for sharing her expertise & time with the
#IBD
community!
0
3
2
reposted by
Puja Khanna, MD
Cedars Sinai IBDI
3 days ago
A well-deserved recognition for Dr. Maria Abreu β€οΈ Our Executive Director has been named one of Becker's 5 GI Power Players, spotlighting her nearly 300 peer-reviewed publications and her leadership in advancing IBD research and care nationwide. We are so proud to have her leading our Institute.
loading . . .
https://www.beckersasc.com/gastroenterology-and-endoscopy/5-gi-power-players-2/
0
6
3
reposted by
Puja Khanna, MD
Cedars Sinai IBDI
5 days ago
Dr. Felix Zhou representing Cedars-Sinai and presenting outcomes from our IBD Prehabilitation Program at
#DDW2026
β fewer complications, fewer readmissions, and lower costs after surgery. We couldn't be prouder π
#IBD
#CrohnsDisease
#UlerativeColitis
#GIHealth
0
4
2
reposted by
Puja Khanna, MD
Cedars Sinai IBDI
9 days ago
Exciting data for hard-to-treat IBD π Phase 2b results from the DUET-UC trial show a dual-antibody therapy targeting both IL-23 and TNF outperformed either drug alone in patients with refractory ulcerative colitis β presented by our own Dr. Maria Abreu at DDW 2026.
#IBD
#UlcerativeColitis
#DDW2026
loading . . .
https://touchimmunology.com/insight/dual-antibody-strategy-shows-promise-in-refractory-ulcerative-colitis-in-the-duet-uc-phase-2b-trial/
0
5
3
reposted by
Puja Khanna, MD
Cedars Sinai IBDI
10 days ago
Exciting work by Dr. Robert Barrett showing that Paneth cells can be enriched in iPSC-derived human intestinal organoids and are responsive to cytokines/microbes/metabolites. This now permits investigations into how this specialized intestinal epithelial subtype plays a role in IBD.
#IBD
#GIHealth
loading . . .
ClinicalKey
https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S2352345X26000470?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2352345X26000470%3Fshowall%3Dtrue&referrer=https:%2F%2Fwww.linkedin.com%2F
0
3
2
reposted by
Puja Khanna, MD
Cedars Sinai IBDI
12 days ago
Today is World IBD Day π IBD affects millions of people worldwide, and our team at Cedars-Sinai is honored to care for this community every day. Watch as Dr. Melmed explains what IBD is and why awareness matters.
#WorldIBDDay
#IBD
#CrohnsDisease
#UlcerativeColitis
loading . . .
0
5
2
Living with IBD means listening to your body. At the Cedars-Sinai IBD Center, we believe: You know your body best. We want every woman to know - you should never feel dismissed, minimized, or unheard. Because your symptoms are real. Your instincts matter. Your body is telling an important story.
13 days ago
0
5
1
reposted by
Puja Khanna, MD
Cedars Sinai IBDI
13 days ago
Tomorrow is World IBD Day! Cedars-Sinai's internationally recognized IBD specialists are dedicated to providing the best care and finding a cure.
#IBD
#CrohnsDisease
#UlerativeColitis
#GIHealth
@pujakhannamd.bsky.social
0
3
2
reposted by
Puja Khanna, MD
Cedars Sinai IBDI
16 days ago
Join us tomorrow! Dr.
@pujakhannamd.bsky.social
will be a guest on a live recording of
@connectingtocure.bsky.social
podcast, "A Body Owner's Guide to IBD." Purchase tickets here:
e.givesmart.com/events/Odp/
#IBD
#CrohnsDisease
#UlerativeColitis
#GIHealth
@aboutibd.bsky.social
0
5
3
reposted by
Puja Khanna, MD
Cedars Sinai IBDI
19 days ago
New hope for patients with treatment-resistant IBD! Researchers, including Dr. Maria Abreu, presented groundbreaking findings showing novel co-antibody therapy outperforms single treatments in refractory Crohn's & ulcerative colitis. Read the full story:
www.medpagetoday.com/meetingcover...
#IBD
loading . . .
Co-Antibody Therapy Effective in Highly Refractory IBD
The combination showed efficacy exceeding that of either monotherapy
https://www.medpagetoday.com/meetingcoverage/ddw/121185
0
8
2
reposted by
Puja Khanna, MD
Cedars Sinai IBDI
20 days ago
A major breakthrough in ulcerative colitis research! The IBD Instituteβs Executive Director, Maria Abreu, led a landmark study showing that a new combination therapy may offer hope to patients who previously had limited treatment options. Read the full story.:
www.nbcnews.com/health/healt...
loading . . .
https://www.nbcnews.com/health/health-news/new-combination-treatment-ibd-ulcerative-colitis-crohns-β¦
0
4
2
reposted by
Puja Khanna, MD
Cedars Sinai IBDI
23 days ago
We are excited to share that Dr.
@pujakhannamd.bsky.social
will be a guest on a live recording of Connecting to Cure's podcast, "A Body Owner's Guide to IBD." Please join us at Telescopic Studio on May 16th! Purchase tickets here:
e.givesmart.com/events/Odp/
0
5
2
you reached the end!!
feeds!
log in